Trade Summary

2 days ago, Keyser D Jeffrey, serving as Dir at Lantern Pharma Inc. (LTRN), purchased 48,544 shares at $2.06 per share, for a total transaction value of $100,001.00. Following this transaction, Keyser D Jeffrey now holds 94,303 shares of LTRN.

This purchase represents a 106.00% increase in Keyser D Jeffrey's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 4:10 PM ET, 2 days after the trade was made.

Lantern Pharma Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.